Paradigm Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.45M | Hold |
51,733
| – | – | 0.34% | 115 |
|
|
2025
Q4 | $1.29M | Sell |
51,733
-3,100
| -6% | -$78.2K | 0.3% | 155 |
|
|
2025
Q3 | $1.4M | Hold |
54,833
| – | – | 0.32% | 119 |
|
|
2025
Q2 | $1.33M | Buy |
54,833
+11,700
| +27% | +$273K | 0.33% | 124 |
|
|
2025
Q1 | $1.09M | Hold |
43,133
| – | – | 0.29% | 150 |
|
|
2024
Q4 | $1.14M | Sell |
43,133
-400
| -0.9% | -$10.8K | 0.31% | 122 |
|
|
2024
Q3 | $1.26M | Hold |
43,533
| – | – | 0.33% | 130 |
|
|
2024
Q2 | $1.22M | Sell |
43,533
-1,100
| -2% | -$30.3K | 0.34% | 113 |
|
|
2024
Q1 | $1.24M | Sell |
44,633
-1,400
| -3% | -$38.8K | 0.31% | 126 |
|
|
2023
Q4 | $1.33M | Sell |
46,033
-1,200
| -3% | -$36.3K | 0.35% | 102 |
|
|
2023
Q3 | $1.57M | Sell |
47,233
-2,400
| -5% | -$84.9K | 0.44% | 60 |
|
|
2023
Q2 | $1.82M | Buy |
49,633
+5,200
| +12% | +$202K | 0.49% | 51 |
|
|
2023
Q1 | $1.81M | Sell |
44,433
-150
| -0.3% | -$6.48K | 0.5% | 51 |
|
|
2022
Q4 | $2.28M | Sell |
44,583
-4,800
| -10% | -$230K | 0.64% | 25 |
|
|
2022
Q3 | $2.16M | Sell |
49,383
-400
| -0.8% | -$19.4K | 0.72% | 33 |
|
|
2022
Q2 | $2.61M | Hold |
49,783
| – | – | 0.8% | 27 |
|
|
2022
Q1 | $2.58M | Hold |
49,783
| – | – | 0.68% | 33 |
|
|
2021
Q4 | $2.94M | Buy |
49,783
+3,383
| +7% | +$168K | 0.73% | 28 |
|
|
2021
Q3 | $2M | Sell |
46,400
-2,300
| -5% | -$102K | 0.55% | 45 |
|
|
2021
Q2 | $1.91M | Hold |
48,700
| – | – | 0.49% | 51 |
|
|
2021
Q1 | $1.76M | Sell |
48,700
-1,400
| -3% | -$49.7K | 0.47% | 55 |
|
|
2020
Q4 | $1.84M | Sell |
50,100
-14,299
| -22% | -$524K | 0.51% | 51 |
|
|
2020
Q3 | $2.24M | Sell |
64,399
-9,803
| -13% | -$344K | 0.7% | 22 |
|
|
2020
Q2 | $2.3M | Sell |
74,202
-6,851
| -8% | -$233K | 0.71% | 21 |
|
|
2020
Q1 | $2.51M | Hold |
81,053
| – | – | 0.97% | 12 |
|
|
2019
Q4 | $3.01M | Buy |
81,053
+5,428
| +7% | +$193K | 0.9% | 13 |
|
|
2019
Q3 | $2.58M | Sell |
75,625
-16,864
| -18% | -$613K | 0.85% | 17 |
|
|
2019
Q2 | $3.8M | Buy |
92,489
+6,114
| +7% | +$243K | 1.1% | 9 |
|
|
2019
Q1 | $3.48M | Sell |
86,375
-4,006
| -4% | -$160K | 1.02% | 10 |
|
|
2018
Q4 | $3.74M | Buy |
90,381
+88,747
| +5,431% | +$3.68M | 1.21% | 8 |
|
|
2018
Q3 | $68.3K | Sell |
1,634
-105
| -6% | -$4.04K | 0.02% | 356 |
|
|
2018
Q2 | $59.9K | Hold |
1,739
| – | – | 0.02% | 348 |
|
|
2018
Q1 | $58.6K | Hold |
1,739
| – | – | 0.02% | 347 |
|
|
2017
Q4 | $59.8K | Buy |
+1,739
| New | +$59.3K | 0.02% | 349 |
|
|
2016
Q4 | – | Sell |
-390,191
| Closed | -$12.5M | – | 626 |
|
|
2016
Q3 | $12.5M | Sell |
390,191
-40,368
| -9% | -$1.35M | 2.19% | 1 |
|
|
2016
Q2 | $14.4M | Buy |
+430,559
| New | +$13.7M | 2.51% | 1 |
|
Other funds holding PFE
VCM
VPM
Paradigm Asset Management's PFE Position: Q1 2026 in Review
Paradigm Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 51,733 shares worth $1.45M. The position accounts for 0.34% of the portfolio, ranked #115.
Paradigm Asset Management first reported a position in PFE in Q2 2016 and has held it in 36 quarters since. The position peaked at $14.4M in Q2 2016. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Paradigm Asset Management held 51,733 shares of Pfizer worth $1.45M as of Q1 2026.
- Paradigm Asset Management left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.34% of Paradigm Asset Management's portfolio in Q1 2026, its #115 holding.
- Paradigm Asset Management first reported a position in Pfizer in Q2 2016 and has held it in 36 quarters since.
- Paradigm Asset Management's Pfizer position peaked at $14.4M in Q2 2016.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.